Biotech 2050 Podcast cover image

Advancing Drug Discovery with Cutting-Edge AI & Team Synergy: Fabrice Chouraqui, CEO of Cellarity

Biotech 2050 Podcast

00:00

Revolutionizing Drug Discovery with AI

This chapter delves into the innovative impact of artificial intelligence on drug development at Celerity, emphasizing a shift from isolated targets to broader cellular dysfunctions. It highlights the need for a multidisciplinary approach in forming effective teams that combine diverse expertise to fully leverage AI's capabilities in creating new treatments.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app